Baseline data with an indication that the treatment group had more severe airways obstruction as well as worse health-related quality of life
| TLD | Sham | |
| Age (years) | 62 | 62.5 |
| Body mass index (kg·m−2) | 25 | 25.5 |
| Smoking (pack-years) | 37 | 42.5 |
| FEV1 (L) | 0.92 | 1.4 |
| FEV1 (%) | 40 | 44 |
| SGRQ-C | 51 | 44 |
| CAT | 18 | 15 |
| mMRC | 2 | 2 |
TLD: targeted lung denervation; FEV1: forced expiratory volume in 1 s; SGRQ-C: St George's Respiratory Questionnaire for COPD patients; CAT: COPD Assessment Test; mMRC: modified Medical Research Council dyspnoea scale.